All In Biotech

Drug Trial Radar · NCT06098079

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

A Phase IV Study to Assess the Effect of Naltrexone Hydrochloride Extended Release (ER) and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on the Occurrence of Major Adverse Cardiovascular Events

Last checked: Nov 19, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 8,600 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

8,600

Planned (sponsor's estimate)

Start

Jan 3, 2024

Primary completion

Jan 2029

Study completion Jul 2029

Sponsor

Lead sponsor
Currax PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 24, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Conditions

  • Obesity

Interventions

  • Naltrexone-Bupropion (NB) CombinationDrug

    A total daily dosage of two NB 8 mg/90 mg tablets twice daily (32 mg/360 mg) is reached at the start of Week 4.

  • PlaceboDrug

    A total daily dosage of two placebo tablets twice daily (in an identical, non-medicine containing tablet) is reached at the start of Week 4.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Occurrence of Cardiovascular DeathTime frame: Treatment initiation through 1 year following treatment termination.
  2. Occurrence of Non-fatal Myocardial Infarction (MI)Time frame: Treatment initiation through 1 year following treatment termination.
  3. Occurrence of Non-fatal StrokeTime frame: Treatment initiation through 1 year following treatment termination.

Locations

140 sites in 1 country. Site status is shown where the registry gives one.

  • TrialMed Birmingham (DRS)

    Birmingham, Alabama

  • Accel Research Sites Network

    Birmingham, Alabama

  • Cullman Clinical Trials

    Cullman, Alabama

  • AMR Mobile

    Mobile, Alabama

  • Velocity Clinical Research, Mobile

    Mobile, Alabama

  • Sun City Research

    Glendale, Arizona

  • Cardiovascular Consultants/NextStage Clinical Research

    Glendale, Arizona

  • Desert Clinical Research

    Mesa, Arizona

  • Velocity Clinical Research, Phoenix

    Phoenix, Arizona

  • Fiel Family & Sports Medicine CCT Research

    Tempe, Arizona

  • Synexus Clinical Research US; Inc.

    Tucson, Arizona

  • Velocity Clinical Research, Gardena

    Anderson, California

  • Velocity Clinical Research

    Chula Vista, California

  • Velocity Clinical Research, Huntington Park

    Huntington Park, California

  • Velocity Clinical Research, San Diego

    La Mesa, California

  • Chemidox Clinical Trials Inc.

    Lancaster, California

  • Long Beach Clinical Trials

    Long Beach, California

  • Velocity Clinical Research

    Los Angeles, California

  • Valley Vitality Ventures

    Manteca, California

  • National Institute of Clinical Research, Inc.

    Pomona, California

  • Velocity Clinical Research, San Bernardino

    San Bernardino, California

  • Velocity Clinical Research at Coastal Heart Medical Group

    Santa Ana, California

  • Velocity Clinical Research of Santa Ana

    Santa Ana, California

  • Velocity Clinical Research, Van Nuys

    Van Nuys, California

  • Providere Research

    West Covina, California

  • Velocity Clinical Research, Denver

    Englewood, Colorado

  • ABMED Clinical Research

    Cape Coral, Florida

  • LMG Research

    Coral Gables, Florida

  • JY Research Institute

    Cutler Bay, Florida

  • Delray Physician Center

    Delray Beach, Florida

  • D&H Doral Research Center

    Doral, Florida

  • Accel Research Sites Network - Edgewater

    Edgewater, Florida

  • Velocity Clinical Research (New Smyrna Beach)

    Edgewater, Florida

  • IMRC Fort Lauderdale

    Fort Lauderdale, Florida

  • Southwest General Healthcare Center

    Fort Myers, Florida

  • G+C Research Group

    Hialeah, Florida

  • Qway Research

    Hialeah, Florida

  • Conveinent Medical Research

    Hialeah, Florida

  • Ilumina Medical Research

    Kissimmee, Florida

  • Altus Research

    Lake Worth, Florida

Showing 40 of 140 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.